Figure 8. A, Analysis of splenic lymphocyte proliferation, (B) interleukin (IL)-4 expression level, and (C) interferon (IFN)-γ expression level in each group. Data are reported as means and SD. *P<0.05 compared to control group and negative group; ^#P<0.05 compared to EgG1Y162 group (ANOVA).